OPTI + AREDS 2 Trademark Application
Summary
The USPTO has received an intent-to-use trademark application for 'OPTI + AREDS 2' filed on May 24, 2025. The application covers dietary and nutritional supplements for eye health.
What changed
The United States Patent and Trademark Office (USPTO) has recorded an intent-to-use trademark application, identified as TM99201274, for the mark 'OPTI + AREDS 2'. The application was filed on May 24, 2025, and pertains to dietary and nutritional supplements intended for eye health.
This filing represents a new trademark application and does not impose any immediate compliance obligations on regulated entities. Companies in the pharmaceutical and dietary supplement sectors should note this filing as it may indicate future market activity or product launches related to eye health supplements.
Archived snapshot
Mar 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
← USPTO Trademark Applications
OPTI + AREDS 2
Intent to Use TM99201274 Kind: intenttouse Mar 22, 2026
Abstract
Dietary and nutritional supplements for eye health
Filing Date
2025-05-24
Related changes
Get daily alerts for USPTO Trademarks - Pharmaceuticals (Class 005)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Trademarks - Pharmaceuticals (Class 005) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.